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At a Glance Commentary 
 
Scientific knowledge on the Subject 
Although non-communicable lung disease is thought to be an important determinant of 
morbidity and mortality in sub-Saharan Africa, valid burden of disease estimates are lacking.  
 
What This Study Adds to the Field 
We found that over 40% of the Malawian adults in our urban population-representative 
sample had abnormal lung function (mostly spirometric restriction) described using NHANES 
reference ranges in the context of widespread exposure to biomass smoke and high HIV 
prevalence. 
 
Online data supplement 
This article has an online data supplement, which is accessible from this issue's table of 
content online at www.atsjournals.org 
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ABSTRACT 
 
Rationale 
Non-communicable diseases (NCD) are major causes of morbidity and mortality in sub-
Saharan Africa (sSA). Valid burden of disease estimates are lacking for non-communicable 
lung disease in sSA.  
 
Objectives 
We performed a community-based survey to determine the prevalence of chronic lung 
disease amongst adults ≥18 years in Malawi, using ATS standard spirometry, internationally 
validated respiratory symptom and exposure questionnaires, and including assessment of 
HIV-status.   
 
Methods 
An age and gender stratified random sample of 2000 adults was taken from the population 
of Chilomoni district of Blantyre, Malawi. Fieldworkers collected questionnaire data, 
conducted HIV-testing and performed pre/post bronchodilator spirometry on eligible 
participants. Survey-weighted population prevalence estimates of respiratory symptoms and 
spirometric abnormalities were computed, and bivariate and multivariable regression were 
used to identify associated variables.  
 
Results 
Questionnaire data, HIV status and BOLD standard spirometry were obtained from 1059, 
937 and 749 participants respectively. Current respiratory symptoms, exposure to biomass 
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and ever smoking were reported by 11.8%, 85.2% and 10.4% respectively. HIV prevalence 
was 24.2%. Moderate-severe airway obstruction was seen in 3.6%. The prevalence of 
spirometric restriction was 38.6% using NHANES reference ranges and 9.0% using local 
reference ranges. Age was positively associated with obstruction while low BMI was 
associated with restriction.  
 
Conclusions 
Over 40% of the Malawian adults in our urban population-representative sample had 
abnormal lung function (mostly restrictive) in the context of widespread exposure to 
biomass smoke and high HIV prevalence. These findings have potentially major pubic health 
implications for Malawi and the broader sSA region. 
 
Word count  
245 words 
 
Index terms - MeSH 
Population surveillance 
Cross sectional studies 
Pulmonary Disease, Chronic Obstructive / epidemiology 
Smoking/epidemiology 
Smoking/adverse effects 
Air pollution, indoor/epidemiology 
Air pollution, indoor/adverse effects 
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INTRODUCTION 
 
Non-communicable diseases (NCD) pose a major health and development challenge to low 
and middle-income countries (LMICS) in the 21st century: 28 million NCD-related adult 
deaths were seen in LMICS in 2012, and cumulative economic losses of US $7 trillion due to 
NCDs are forecast for these regions by 2025 if better control and prevention measures are 
not instituted (1). The need for prioritisation of NCDs was recognised in the World Health 
Organisation NCD Global Action Plan, adopted in 2013 (2). 
 
Chronic respiratory diseases are the fourth leading cause of NCD deaths globally, and burden 
of disease estimates place chronic obstructive pulmonary disease (COPD) as the twelfth 
most common cause of years of life lost globally (3). Despite the likely high global burden of 
chronic respiratory disease, there are limited data on its prevalence, natural history, and 
associated morbidity and mortality in LMICS (4). Information on chronic respiratory disease 
in sub-Saharan Africa (sSA) is especially scarce (5). Existing information suggests the burden 
in this setting may be high: the international Burden of Obstructive Lung Disease (BOLD) 
study (www.boldstudy.org) demonstrated a considerably higher prevalence of moderate to 
severe airway obstruction amongst adults ≥40-years in Cape Town, South Africa (19.1%) 
compared to that seen in Western Europe and North American settings  (5.9-14.3%) (6). A 
higher prevalence of chronic respiratory disease in sSA is biologically plausible based on the 
intersection of several acknowledged risk factors for respiratory pathology in these settings, 
including poverty-related in-utero and early childhood exposures, biomass fuel exposure, a 
rapidly increasing prevalence of smoking, lung damage caused by pulmonary TB, and chronic 
HIV-infection (1, 7-11). In addition, an association between restrictive lung diseases or low 
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respiratory volumes and mortality has been observed in ecological and prospective cohort 
studies (12),(13). 
 
We report the results of a community-based prevalence study of respiratory disease 
conducted to BOLD study standards amongst adults ≥18 years in Blantyre, Malawi. The study 
includes information on respiratory symptoms, exposures, HIV status and spirometry. Our 
aim was to define the burden of respiratory symptoms and obstructive and restrictive lung 
disease in this setting, and to explore their risk factors.  
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METHODS 
An age (18-39 and ≥40 years) and gender stratified population-representative sample of 
2000 adults was taken from an enumerated population of Chilomoni district of urban 
Blantyre, Malawi (14). Fieldworkers conducted home-visits to assess eligibility and seek 
informed consent between February 2013 and August 2014. Individuals were excluded if not 
permanent residents of the area, pregnant or acutely unwell. Up to 3 repeat visits were 
conducted to locate initially absent residents (eMethods section, Online data supplement).  
 
Standardised BOLD questionnaires about respiratory symptoms and exposures were 
administered in the local language, Chichewa(15). Pre and post-bronchodilator spirometry 
were performed to American Thoracic Society (ATS) standards using the ndd EasyOne 
Spirometer (ndd Medical Technologies; Zurich, Switzerland)(16). Anthropometric 
measurements and a blood sample taken for HIV and haematology assays were taken. 
Participants were given the results of clinical observations and spirometry measurements at 
the point of testing. HIV-test results were communicated to participants who wished to 
know their results. Minimal questionnaire data were collected from patients who declined 
to participate in the full study. Quality assurance of questionnaire and spirometry data was 
provided by the central BOLD co-ordinating centre. 
 
A target sample size of 1200 adults completing the study, split equally between men and 
women, and those 18-39 years and ≥40 years old, was chosen to allow stratified prevalence 
estimates of spirometric abnormalities with acceptable precision, in accordance with the 
BOLD protocol.  
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Participants who completed full and minimal questionnaires, and adequate or inadequate 
spirometry, were compared to assess for selection bias using the Chi-square or Student’s t-
test. In order to allow comparison with data from other BOLD study sites, age and gender 
stratified prevalence estimates of spirometric abnormalities (Table 1) were reported using 
reference ranges derived for Caucasian subjects from NHANES III (The third National Health 
& Nutrition Examination Survey, USA, 1988-1994) and local ranges derived within this study 
from the spirometry of non-smoking adults with no history of respiratory disease or 
symptoms  (15).  
 
Bivariate associations between spirometric abnormalities and exposure variables including 
age, gender, participant education, HIV-status, self-reported previous TB, haemoglobin, 
eosinophilia, body mass index (BMI), smoking status, smoking pack-year exposure, indoor 
biomass exposure, and occupational exposures were examined. Home ownership and 
household water and sanitation were used as proxy markers of socioeconomic status (SES). 
No adjustments were made for multiple tests in exploratory analyses. Multivariable logistic 
regression models were constructed including age and gender a-priori, and variables with a 
p-value <0.2 on bivariate analysis. A manual forwards stepwise regression technique was 
used to develop multivariable models.  Missing data were imputed using simple univariate 
procedures, and sensitivity analyses used to compare results with complete case analyses. 
Prevalences of respiratory symptoms were described, and regression analyses used to 
identify associated variables. The associations between abnormal spirometry and respiratory 
symptoms were described. Analyses were conducted using STATA (Stata Statistical Software: 
Release 13. College Station, TX: StataCorp LP). Survey weighting was employed to calculate 
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population representative prevalence estimates and develop regression models using the 
Svy package in Stata (15). 
 
Ethical approval was given by the National Research Ethics Committee of Malawi and the 
Liverpool School of Tropical Medicine Research Ethics Committee (Protocol 12.08). 
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RESULTS  
Of the 2000 randomly selected adults, 1469 (73.5%) were located by fieldworkers and 1240 
(62.0%) were eligible for inclusion. Of eligible adults, 85.4% (1059/1240) consented to 
participate and completed the full BOLD questionnaire, with 70.7% (749/1059) performing 
ATS standard spirometry  (Figure 1).  
 
Participant characteristics 
Mean participant age was 41.9 years (SD 15.3), and 57.9% were male. Overall 37.4% were 
educated to primary school level only. Although 59.3% of participants were from households 
that owned their own home, only 25.1% had access to flush toilets and 46.6% had a private 
indoor or outdoor water supply  (Table 2). Eligible individuals who declined to participate in 
the study but provided minimal data were more likely to be male (56.3% vs. 43.7%) and 
current smokers (9.0% vs. 4.3%) than those contributing full data (Table E1, Online data 
supplement).   
 
Respiratory exposures 
Smoking exposure was more frequently reported in men: 9.2% of men and 0.7% of women 
were current smokers; 12.8% of men and 1.3% of women were ex-smokers (Table 2). 80.9% 
of those who had smoked reported <10 pack-years of exposure. Self-reported biomass 
exposure was more common than cigarette smoking: 85.2% reported use of a biomass fuel 
(mostly charcoal) for cooking on an open fire for ≥6 months, and 31.9% reported the use of 
an open fire burning wood, dung, or crop residues for heating water. Farming was the 
reported occupation of 29.2% of participants. 
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Comorbidities  
7.9% of the population had low BMI (<18.5 kg/m
2
), 20.8% were overweight (BMI 25-30 
kg/m2), and 12.9% were obese (BMI>30 kg/m2). Only 2.9% reported previous TB.  
 
Blood results 
Data on HIV status were available for 88.1% of those who completed the core questionnaire, 
of whom 24.2% were HIV-infected. Haemoglobin levels were normally distributed with mean 
13.9g/dL (SD 1.8) and range 6.7-21.4 g/dL. The median white cell count (WCC) was 5.0 (IQR: 
4.1-5.9); 68.6% of participants had blood eosinophil counts exceeding 2.0% of the total WCC.  
 
Respiratory symptoms 
Overall 11.8% (SE 1.2) of participants had at least 1 respiratory symptom, and 5.0% (SE 0.8) 
reported respiratory problems interfering with their daily activities. Cough was reported by 
7.5% (SE 0.9) of participants, but chronic cough (cough present on most days for ≥3 
months/year) by only 0.5% (SE 0.2). Only 0.2% (SE 0.2) of all adults reported chronic sputum 
production (phlegm on most days for ≥3 months/year). Breathlessness was described by 
3.6% (SE 0.7) of participants; 21.2% (SE 8.5) of this group had severe functional impairment 
and reported stopping for breath after walking 100 yards on a flat surface (modified MRC 
breathlessness score = 3). Wheeze within the past year in the absence of an upper 
respiratory tract infection was reported by 1.4% (SE 0.4) (Figure 2, Table E2 of Online Data 
Supplement).  
 
Spirometry  
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Three factors were statistically significantly associated with completion of ATS standard 
spirometry: lower median age [41.0 years (IQR: 28-51) vs. 44.0 years, (IQR: 31-56))], higher 
mean haemoglobin [14.07(SD 1.80) vs. 13.62(SD 1.76)], and a greater average number of 
years of education [9.47(SD 4.20) vs. 8.85(4.65)]. No other statistically significant differences 
were identified at alpha = 0.05 level between groups who did and did not complete 
spirometry (Table E3, Online Data Supplement). 
 
4.3% (SE 1.1) of men and 4.1% (SE 1.1) of women had post-bronchodilator obstruction 
(FEV1/FVC <0.7) on spirometry. A high proportion of this was at least moderate in severity: 
3.2% (SE 1.0) of men and 3.9% (SE 1.0) of women had an FEV1 <80% predicted using the 
NHANES reference ranges, and 2.0% (SE 0.7) of men and 2.7% (SE 0.9) of women using local 
reference ranges (Figure 3, Table E4 of Online Data Supplement). Any obstruction and 
moderate-severe obstruction were seen in 2.9% (SE 0.9) and 2.6% (SE 0.9) of 18-39 year 
olds, and 9.0% (SE 1.4) and 7.0% (SE 1.2) of ≥40 year olds. 
 
Spirometric restriction was more common than obstruction in both genders and across age-
group strata. The estimated prevalence was considerably higher when NHANES reference 
ranges were used (38.6%, SE 2.1) compared to locally derived reference ranges (9.0%, SE 
1.2). Airway reversibility was present in 4.2% (0.8) of the cohort, but only 17.3% (SE 7.7) of 
those with reversibility had airway obstruction following bronchodilator. 
 
 
Factors associated with respiratory symptoms 
Ever smoking was positively associated with both cough and sputum production in bivariate 
analysis (Table E5, Online Data Supplement), and in multivariable analysis the odds of usual 
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cough were 2.37 higher in current vs. never smokers (95% CI 1.12-5.02) (Table 3). The odds 
of regular sputum expectoration were 5.94 times higher (95% CI 1.95-18.06) in those with 
previous biomass exposure compared to those without. Employment in farming was 
positively associated with all symptoms in bivariate analyses, and the odds of exertional 
breathlessness remained significantly higher (OR 6.32, 95% CI: 1.87-21.32) in those 
employed in farming for >3 months compared to non-farmers in multivariable analysis. 
 
Women were less likely to report cough or sputum production in bivariate analyses, and 
their odds of cough remained lower (OR 0.31, 95% CI 0.15-0.65) than men in multivariable 
analysis. Low BMI was positively associated with wheeze and sputum production in bivariate 
analysis, and the odds of usual sputum production remained 3.49 (95% CI 1.37 – 8.86) times 
higher in those with BMI<18.5kg/m
2
 compared to normal weight in the multivariable model. 
No statistically significant relationships between symptoms and markers of SES or education 
persisted in multivariable models. One-third of those with cough were HIV-infected, and a 
positive association was seen between cough and HIV-infection (OR 1.94, 95% CI 1.10-3.44). 
HIV-infection was not associated with other respiratory symptoms. Self reported previous TB 
was not statistically associated with any symptoms. Moderate-severe obstruction, 
restriction, or reversibility, defined using NHANES III reference ranges were not associated 
with respiratory symptoms (Table E6, Online Data Supplement). 
 
Factors associated with post-bronchodilator airway obstruction 
Participant age was the factor most clearly associated with airway obstruction in bivariate 
and multivariable analyses, increasing in a non-linear fashion with a 10.12 times higher risk 
of moderate to severe obstruction (95% CI 3.54-28.93) in those aged ≥60 years compared to 
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18-29 year olds (Table 4, Tables E7 & E8 in Online Data Supplement). This finding was also 
seen in the sensitivity analysis restricted to complete-case data.  No association was seen 
between HIV-infection or biomass exposure and airway obstruction. Individuals without 
access to private water supply had 2.44 times higher risk of moderate to severe obstruction 
in multivariable analysis (95% CI 1.01 – 5.88).   
 
Factors associated with spirometric restriction 
BMI was strongly associated with restrictive deficit defined using NHANES criteria: those 
who were underweight had 4.09 (95% CI 2.04-8.22) times higher odds of restriction 
compared to those with normal weight in the multivariable model. Older age was negatively 
associated with restriction, and those aged over 60-years had 0.53 (95% CI: 0.29-0.96) times 
the odds of restriction of the 18-29 year group. No other risk factors for restrictive deficit 
were identified in the multivariable model (Table 5, Table E9 in Online Data Supplement).  
 
When spirometric restriction was defined using local reference ranges (Table E10, Online 
Data Supplement), no clear trend in the relationship between age and restriction emerged. 
The odds of restriction were higher if underweight (OR 2.80, 95% CI 1.19-6.55) in bivariate 
analysis only. In multivariable analysis, previous TB was associated with higher odds of 
restriction (OR 3.01, 95% CI 1.07-8.50). 
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DISCUSSION 
We conducted a population based cross-sectional study of the prevalence of and risk 
factors for non-communicable respiratory disease conducted to BOLD standards 
amongst adults aged ≥18 years in Malawi. We found a high burden of chronic 
respiratory symptoms and abnormal spirometry in the population, with an especially 
high burden of spirometric restriction, and large differences in the estimated 
prevalence of restriction using NHANES and locally defined reference ranges. 
 
Abnormal spirometry is defined in relation to age, height, and gender standardised 
predicted values. Two different reference ranges were used in this analysis: the 
NHANES reference range is drawn from a healthy Caucasian population in the US 
and is thought to represent the best possible lung function in the absence of any 
known detrimental respiratory exposures; the locally derived reference range 
reflects the spirometry of non-smoking symptom-free Malawian adults within this 
study. Whilst values may be ethnically more appropriate in the latter, they are also 
constrained by common exposures within in this setting (17). The marked difference 
in the burden of restriction defined using NHANES (38.6%) vs. reference ranges 
determined from our study population (9.0%) suggests that on average, Malawian 
adults have smaller lungs than US Caucasian populations. This finding is consistent 
with previous studies that have demonstrated lower FVC ranges in populations from 
resource-poor settings (12).  
 
The cause of this difference is unclear. The role of ethnicity must be considered, as 
body frame differences related to ethnicity are known to effect lung function (18). 
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However, it has been suggested that in-utero and early childhood exposures 
including suboptimal in-utero conditions, low birth weight, respiratory tract 
infections, and nutritional deficiencies can predict adult lung health and are more 
prevalent in resource poor settings (7, 19, 20). Although the use of height 
standardised spirometry reference ranges here may have ‘controlled’ for stunting 
related to childhood nutritional deficits, a low BMI was strongly associated with 
NHANES defined spirometric restriction. This is consistent with an ongoing 
nutritional influence on FVC, and the finding of small lungs in adults may be 
explained by poor nutrition causing impaired lung growth at vulnerable stages of 
lung development. Interest in the link between acute and chronic malnutrition and 
long-term disability is growing(21), and prospective studies into the effect of lung 
function in later life would fit well within this agenda.   
 
The morbidity and mortality associated with the lower FVC we have identified in the 
Malawian setting remain poorly described. Spirometric restriction has been shown 
to be associated with increased mortality, even in the absence of respiratory 
symptoms and a diagnosis of respiratory disease, in both the US setting and 
ecological studies (12, 13). The negative correlation seen between spirometric 
restriction and age here may represent a birth cohort effect, whereby the incidence 
of restriction is decreasing over time, but would also fit with earlier mortality 
amongst those with restriction. Prospective studies are required to investigate the 
prognostic implications of restriction in sSA settings, and to determine the public 
health implications of our findings.  
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Cough was the most common respiratory symptom reported by participants. The 
association with HIV raises the possibility that undiagnosed pulmonary tuberculosis 
may be responsible for part of this presentation (22-26). However, cough was less 
prevalent amongst younger age groups in whom the TB incidence would be expected 
to be highest. In addition, the association of chronic cough with ever smoking and 
the strong association between sputum production and biomass smoke exposure 
also suggest that bronchial irritation from smoke inhalation with a degree of chronic 
bronchitis may underlie these symptoms. It is however of note that no association 
was seen between spirometric results and respiratory symptoms. Further 
investigation of the relationship between structural lung pathology, abnormal airway 
physiology, and respiratory symptoms in this setting is required.  
 
No association was seen in our data between moderate-severe chronic airflow 
obstruction and exposure to tobacco or biomass, although both are recognised risk 
factors for obstruction (27-30). The absence of a relationship between biomass 
exposure and airway obstruction may be explained by limited study power given the 
low prevalence of moderate-severe obstruction (3.6%), or misclassification of self-
reported rather than objectively quantified biomass exposure, but is consistent with 
findings of a recent population-based study in Nigeria (31, 32). In the case of tobacco 
it may also reflect a low intensity of exposure in this setting, which is insufficient to 
produce significant levels of clinically important COPD: smoking prevalence was 
limited and pack-year exposure low.  This is in contrast to the findings of the BOLD 
study conducted in Cape Town, South Africa where the prevalence of moderate to 
severe airway obstruction amongst adults ≥40 was much higher (19.1%) and where 
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ever smoking was much more common (59% vs 16%) amongst those with COPD (5). 
This illustrates important differences in the epidemiology of respiratory disease 
within sSA: the patterns of exposure and pathology in Cape Town, South Africa may 
be closer to those of a high income and more industrialized setting than those seen 
in Malawi and other low income countries across the region.  
 
Increasing age was the only measured factor significantly associated with airflow 
obstruction in our study. The persistence of this association for moderately severe 
obstruction suggests that this is not simply the result of expected changes in the 
FEV1/FVC ratio seen with aging, but in fact constitutes abnormal pathology (33). 
Small sample size in the context of a low prevalence condition is likely partly 
responsible for the lack of other significant findings. We note with interest the non-
statistically significant positive association between peripheral blood eosinophil level 
and airflow obstruction that was not seen with restriction.  
 
 A major strength of our study is the inclusion of all adults from the age of 18 
years and measurement of HIV-status. Spirometry was conducted to ATS standards, 
with careful quality control. The enumeration of the target population at the start of 
the study, followed by age and gender stratified sampling, allowed for population 
weighted prevalence estimates to be drawn and associations measured.  
 
Limitations of this study include the challenges posed by working with a 
mobile urban population: it was not possible to locate over 25% of the initial random 
sample, and 9.6% had permanently left the area between enumeration and 
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fieldworker home visits. In addition, only 71% of those who were included were able 
to complete adequate spirometry with fewer older individuals. As a result, we did 
not reach the target sample size of 600 adults over and 600 adults under 40-years of 
age with high quality spirometry. This reduced our power to detect significant 
associations in the exploratory analyses. The study was cross sectional in nature and 
whilst efforts were made to assess the impact of respiratory pathology on patients’ 
lives using self-reported symptoms and health related quality of life, prospective 
data are required to determine the impact of respiratory pathology on morbidity and 
mortality over time. Measurement of total lung capacity, in addition to FVC, would 
allow us to better understand the nature and impact of the spirometric restriction 
seen here. Symptomatic individuals were not screened for pulmonary TB, and the 
proportion of abnormalities attributable to this more acute pathology are therefore 
unclear. In addition, the observational nature of this study means that correlations 
identified may not be causal in nature and could be explained by unidentified or 
unmeasured confounding factors. Lastly, our data are drawn from a single urban site 
study, making it difficult to identify strong risk factors for respiratory disease that are 
ubiquitous within the sample population. Ecological studies comparing data from 
diverse populations within sSA, and with Western cohorts will be required to explore 
these determinants. Comparable data from rural settings, and areas with different 
environmental/occupational exposures are required to determine the 
generalizability of our results. 
 
 The key finding of our study is a high burden of restrictive spirometry 
amongst Malawian adults, with a large difference in prevalence using NHANES and 
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locally defined reference ranges. There is a clear and pressing need to better 
understand the aetiology, pathology, epidemiology and prognosis of pulmonary 
restriction in sub Saharan Africa to inform the development of prevention and 
management approaches for this condition. If, as has been seen elsewhere, 
pulmonary restriction in this setting is associated with increased mortality this will 
have major pubic health implications for Malawi and potentially the broader sub-
Saharan Africa region. 
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Figure 1: Participant recruitment flow diagram 
  
Chilomoni Ward 
Target population enumeration & mapping 
N=16079 
Age & gender stratified random sample 
N=2000 
Eligible for inclusion 
N= 1240 
Consented to participate 
18-39 years = 474 
≥40 years = 585 
Acceptable spirometry  
18-39 years = 347 
≥40 years = 402 
Unacceptable spirometry  
18-39 years = 127 
≥40 years =183 
  
  Ineligible for inclusion, n=219 
 Deceased =7 
 Permanently left area = 192 
 Age ineligible =1 
 Medically excluded =19 
  Unable to locate, n=541 
 Incorrect contact information = 10 
 Unable to reach = 531 
  
  Partial data collection, n= 14 
 Refused to participate, n=167 
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Figure 2: Age and gender stratified prevalence of symptoms amongst study participants 
Questions asked: Do you usually have a cough when you don’t have a cold? (n=1056); Do you usually 
bring up phlegm from your chest (n=1056); Have you had wheezing/whistling in your chest at any 
point in in the past 12 months, in the absence of a cold (n=1007); Do you have shortness of breath 
hen hurrying on the level or walking up a slight hill (n=970); Have breathing problems interfered with 
your usual daily activities (n=1056). 
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Figure 3: Age and gender stratified prevalence of moderate-severe airway obstruction (FEV1/FVC<0.7 
& FEV1<80% predicted) and spirometric restriction (FEV1/FV>0.7 & FEV1<80%) defined using NHANES 
reference ranges, amongst those completing ATS standard spirometry (n=749) 
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Table 1: Spirometric definitions(34) 
Finding Spirometric definition 
Post bronchodilator obstruction FEV1/FVC Ratio <0.7 
Post bronchodilator moderate to severe 
obstruction 
 
FEV1/FVC ratio <0.7 AND  
FEV1<80% predicted* 
 
Spirometric restriction FEV1/FVC Ratio>0.7 AND  
FVC<80% predicted* 
Airway reversibility FEV1 increase ≥200ml AND ≥12% following 
bronchodilator 
*Age, gender and height standardised predicted values obtained from NHANES III, or local reference ranges derived from 
spirometry results of healthy, never-smoking Malawian subjects. 
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Table 2: Characteristics of participants completing full BOLD core questionnaire, including those with 
and without ATS standard spirometry 
Variable (n) Number (%) 
Mean (SD) 
Age group (n=1058) 
18-29 
30-39 
40-49 
50-59 
60-69 
70+ 
 
 
283 
190 
253 
182 
98 
52    
 
(26.8 %) 
(18.0 %) 
(23.9 %) 
(17.2 %) 
(9.3 %) 
(4.9 %) 
Gender (n=1059) 
Male  
Female 
 
 
446 
613 
 
(42.1 %) 
(57.9 %) 
Level of education (n=1054) 
None 
Primary 
Middle 
High school or college 
 
 
59 
394 
391 
210 
 
 
(5.6 %) 
(37.4 %) 
(37.1 %) 
(19.9%) 
Years of education (n=1057) 
 
9.29 4.35 
HIV status (n=933) 
Negative 
Positive 
 
707 
226  
 
 
(75.8 %)  
(24.2 %) 
Self reported previous TB (n=1057) 
No 
Yes 
 
 
1026 
31 
 
(97.1 %) 
(2.9 %) 
Hemoglobin (g/dL) (n=936) 13.9 (1.80) 
 
Eosinophil blood count >2% (n=927) 
No 
Yes 
 
 
 
291 
636  
 
 
(31.4 %) 
(68.6 %) 
BMI group (kg/m2) (n=972) 
Underweight (BMI<18.5) 
Normal (18.5≥BMI<25) 
Overweight (25≥BMI<30) 
Obese (BMI≥30 
 
77 
568 
202 
125 
 
(7.9 %) 
(58.4 %) 
(20.8 %) 
(12.9 %) 
 
Home ownership (n=1057) 
Yes 
No 
 
 
627 
430 
 
 
(59.3 %) 
(40.7 %) 
 
Access to private water supply (indoor OR outdoor 
tap) (n=1057) 
Yes 
No 
 
 
492 
565 
 
 
(46.6 %) 
(53.4 %) 
 
Household has flush toilet (n=1057) 
Yes 
No 
 
 
 
265 
792 
 
 
(25.1 %) 
(74.9 %) 
Smoking status (n=1057) 
Ever 
Never 
 
 
110 
947 
 
(10.4 %) 
(89.6 %) 
Pack years of smoking (n=1057) 
0 years 
>0 and <10years 
≥10 years 
 
947 
89 
21 
 
(89.6 %) 
(8.4 %) 
(2.0 %) 
 
Biomass exposure* (n=1057) 
No 
 
 
157 
 
 
(14.8 %) 
 34
Yes 900 (85.2 %) 
 
Working in farming >3m (n=1056) 
No 
Yes 
 
 
748 
308 
 
 
(70.8 %) 
(29.2 %) 
*Use of charcoal/coal/coke or burning of wood/dung/crop residue for >6 months for cooking, or burning of wood/dung/crop 
residue for heating water 
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Table 3: Multivariable associations with respiratory symptoms‡ in all age groups, n=1056 
Variable Usual cough (n=103) 
 
Usual sputum (n=51) Exertional dyspnoea (n=35) Wheeze (n=21) 
Odds 
Ratio 
95% CI Odds Ratio 95% CI Odds 
Ratio 
95% CI Odds 
Ratio 
95% CI 
Age group 
18-29 
30-39 
40-49 
50-59 
≥60 
 
1.0 
0.97 
2.37 
1.82 
1.81 
 
- 
0.44-2.17 
1.19-4.71* 
0.87-3.81 
0.85-3.86 
 
1.0 
1.12 
1.97 
3.64 
2.32 
 
- 
0.38-3.12 
0.75-5.16 
1.43-9.26* 
0.82-6.55 
 
1.0 
0.09 
0.28 
0.40 
0.74 
 
- 
0.01-0.80* 
0.08-1.03 
0.11-1.42 
0.18-3.00 
 
1.0 
Empty 
1.97 
0.99 
1.39 
 
- 
- 
0.48-8.06 
0.17-5.73 
0.24-7.93 
 
Gender 
Male 
Female 
 
 
1.0 
0.72 
 
- 
0.41-1.27 
 
- 
0.31 
 
- 
0.15-0.65* 
 
1.0 
1.78 
 
- 
0.68-4.68 
 
1.0 
0.41 
 
- 
0.13-1.27 
Smoking status  
Never 
Ever 
 
 
1.0 
2.37 
 
- 
1.12-5.02* 
     
 
 
 
HIV status§ 
Negative 
Positive 
 
 
1.0 
1.94 
 
- 
1.10-3.44* 
      
Haemoglobin (g/dL) § 
 
      0.74 0.58-0.94* 
Working in farming >3m 
No 
Yes 
 
     
1.0 
6.32 
 
- 
1.87-21.32* 
  
Any biomass exposure† 
No 
Yes 
 
   
1.0 
7.05 
 
 
2.28-21.80* 
    
BMI (kg/m2) 
Underweight (BMI<18.5) 
Normal (18.5≥BMI<25) 
Overweight (25≥BMI<30) 
Obese (BMI≥30) 
   
3.26 
1.0 
0.37 
1.15 
 
1.32-8.07* 
 
0.15-0.91* 
0.31-4.30 
   
5.38 
1.0 
1.16 
5.47 
 
1.23-23.50* 
- 
0.26-5.16 
0.93-32.38 
 
Household has flush toilet  
Yes 
No 
 
   
1.0 
0.42 
 
- 
0.19-0.91* 
    
* p<0.05  
†Use of charcoal/coal/coke or burning of wood/dung/crop residue for >6 months for cooking, or burning of wood/dung/crop 
residue for heating water 
‡Presence of respiratory symptoms ascertained using the following questions, derived from the BOLD study core questionnaire: 
Usual cough: Do you usually cough when you don’t have a cold? 
Usual sputum: Do you usually bring up phlegm from your chest, or do you usually have phlegm in your chest that is difficult to 
bring up, when you don’t have a cold? 
Exertional dyspnea: Are you troubled by breathlessness when hurrying on the level or walking up a slight hill? 
Wheeze: Have you had wheeze/whistling in your chest at any time in the past 12months? In the last 12 months have you had this 
wheeze or whistling only when you have had a cold? (exclude if yes to the latter question) 
§Imputation of data required for 11.9% of HIV values, and 11.8% of haemoglobin values. Imputation of all other values ≤0.1% 
  
Table 4: Multivariable associations of risk factors with NHANES defined moderate-severe post 
bronchodilator airway obstruction (FEV1/FVC ratio <0.7 & FEV1<80% predicted), n=749 
Variable Multivariable association†  
Odds Ratio 95% CI 
Age group 
18-29 
30-39 
40-49 
50-59 
≥60 
 
 
1.0 
1.38 
0.93 
4.66 
10.12 
 
- 
0.36-5.25 
0.27-3.15 
1.58-13.79* 
3.54-28.93* 
Gender 
Male 
Female 
 
 
1.0 
1.34 
 
- 
0.57-3.17 
Access to private water supply (indoor OR 
outdoor tap) 
Yes 
No 
 
 
 
1.0 
2.44 
 
 
- 
1.01-5.88* 
* p<0.05  
†Multivariable model developed using variables correlated at p<0.2 level in bivariate analysis, and age group & gender as 
apriori risk factors, with imputation for missing data. 
 
  
 Table 5: Multivariable associations of risk factors with NHANES defined spirometric restriction 
(FEV1/FVC ratio >0.7 & FVC >80% predicted), n=756 
Variable Multivariable associations† 
Odds Ratio 95% CI 
Age group 
18-29 
30-39 
40-49 
50-59 
 ≥60 
 
1.0 
0.64 
1.00 
0.85 
0.53 
 
 
- 
0.40-1.02 
0.66-1.53 
0.52-1.38 
0.29-0.96* 
 
Gender 
Male 
Female 
 
 
1.0 
0.95 
 
- 
0.65-1.40 
BMI (kg/m2) 
Underweight (BMI<18.5) 
Normal (18.5≥BMI<25) 
Overweight (25≥BMI<30) 
Obese (BMI≥30) 
 
 
4.09 
1.0 
1.07 
1.58 
 
2.04-8.22* 
- 
0.66-1.73 
0.85-2.96 
* p<0.05  
†Multivariable model developed using variables correlated at p<0.2 level in bivariate analysis, and age group & gender as 
apriori risk factors, with imputation for missing data. 
 
